ACADIA PHARMACEUTICALS INC
ACAD
17 insider filings · Latest: Jul 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Jul 31 10:00 PM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Sale | 16,558 | $26.13 | $432.7K | 18,994(D) | View → |
| May 26, 2026 | May 27 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 5,401 | $21.18 | $114.4K | 24,509(D) | View → |
| May 4, 2026 | May 5 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 1,332 | $21.79 | $29.0K | 29,129(D) | View → |
| May 4, 2026 | May 5 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Sale | 3,506 | $21.79 | $76.4K | 66,145(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Jul 31 10:00 PM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Option Exercise | 32,272 | — | 32,272(D) | View → |
| May 29, 2026 | Jun 2 8:32 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Grant/Award | 64,016 | $21.66 | 32,008(I) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Edmund HarriganDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Edmund HarriganDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Adora NduDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Adora NduDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Laura BregeDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Laura BregeDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Jonathan PooleDirector | Option Exercise | 2,010 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Jonathan PooleDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Elizabeth A. GarofaloDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Elizabeth A. GarofaloDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | James M DalyDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | James M DalyDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 1, 2026 | May 5 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 2,596 | — | 2,596(D) | View → |
| May 1, 2026 | May 5 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 6,815 | — | 6,815(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Grant/Award | 28,098 | $22.16 | 6,332(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC | Grant/Award | 117,073 | $22.16 | 26,382(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Grant/Award | 117,073 | $22.16 | 26,382(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Thomas GarnerEVP, Chief Commercial Officer | Grant/Award | 126,440 | $22.16 | 28,493(D) | View → |
Page 1 of 2
Next →